NIST Advanced Technology Program
Return to ATP Home Page Return to ATP Home Page

Highlights from ATP's Economic Studies

1.B.6:   Bringing Benefits of Digital Mammography and Radiography to More People1
Previous FactsheetIndexNext Factsheet

Digital mammography and radiography systems are innovative technology solutions to the diagnostic and productivity limitations of conventional X-ray

  • Between 1995 and 2000, ATP co-funded a joint venture project with General Electric Corporate R&D and PerkinElmer, Inc.2
  • The ATP provided $1.6 million and the companies provided an additional $1.9 million in cost share.
  • The companies developed a low-cost manufacturing process for fabricating amorphous silicon detector panels for digital mammography and radiography systems.

Project Performance

  • The new process, expected to be implemented by 2004, will reduce fabrication costs by approximately 25% without compromising performance:
    • Less complex fabrication with fewer mask steps: 7 vs. 11
    • Fewer total process steps: 200 vs. 300
  • The ATP-funded low-cost manufacturing process is expected to deliver:
    • Additional digital mammography and radiography systems are expected to be sold.
    • More patients will likely experience the benefits of digital mammography and radiography.
    • More health-care facilities will likely experience improved productivity and patient throughput.
  • Total Net Public Benefit to the Nation (excludes benefits to funded companies):
    • Net Present Value of ATP Investment: $219 million to $339 million ($2002)
  • Public Return on ATP investment
    • Internal rate of return on ATP Investment: 69 percent to 77 percent
  • Public Benefit per ATP dollar invested
    • Benefit-to-cost ratio for ATP Investment: 125:1 to 193:1

Broad Societal Benefits

  • Benefits of digital mammography and radiography to medical facility users and patients are much greater than the benefits to the companies that produce them
  • Societal benefits include:
    • Increased throughput, reduced patient examination time, and reduced waiting time
    • Lower false positive rates, and therefore fewer unnecessary biopsies
    • Lower call-back rates for mammogram under- and over exposure, and therefore avoidance of unnecessary procedures
    • Reduced radiation exposure
    • Simplified record retrieval and record management of past mammograms
    • Assistance in use of computer-aided detection (CAD) for improved cancer detection
    • Reduced health disparities across population groups with greater use of telemammography and teleradiology networks.

____________________
1 An ATP contractor study—Dr. Thomas Pelsoci, Delta Research Company, Low-Cost Manufacturing Process Technology for Amorphous Silicon Detectors: Applications in Digital Mammography and Radiography, (NIST GCR 03-844), 2003.

2 Formerly EG&G Reticon.

Factsheet 1.B6 (Updated March 2003)

Return to ATP Home Page ATP website comments: webmaster-atp@nist.gov   /  Technical ATP inquiries: InfoCoord.ATP@nist.gov

NIST is an agency of the U.S. Commerce Department
Privacy policy / Security Notice / Accessibility Statement / Disclaimer / Freedom of Information Act (FOIA) /
No Fear Act Policy / NIST Information Quality Standards / ExpectMore.gov (performance of federal programs)
Return to NIST Home Page
Return to ATP Home Page Return to NIST Home Page Visit the NIST Web Site